Volante M, Collini P, Nikiforov YE, et al. Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol. 2007;31(8):1256-64.

Article  PubMed  Google Scholar 

WHO Classification of Tumours Editorial Board. Poorly differentiated thyroid carcinoma. In: WHO Classification of Tumours Editorial Board, editor. Endocrine and Neuroendocrine Tumours. 10. 5 ed. Lyon, France: International Agency for Research on Cancer (IARC); 2025. p. 123–30.

Asioli S, Erickson LA, Righi A, et al. Poorly differentiated carcinoma of the thyroid: validation of the Turin proposal and analysis of IMP3 expression. Mod Pathol. 2010;23(9):1269-78.

Article  PubMed  Google Scholar 

Bai S, Baloch ZW, Samulski TD, et al. Poorly differentiated oncocytic (hurthle cell) follicular carcinoma: an institutional experience. Endocr Pathol. 2015;26(2):164-9.

Article  CAS  PubMed  Google Scholar 

Dettmer M, Schmitt A, Steinert H, et al. Poorly differentiated oncocytic thyroid carcinoma--diagnostic implications and outcome. Histopathology. 2012;60(7):1045-51.

Article  PubMed  Google Scholar 

Wong KS, Dong F, Telatar M, et al. Papillary Thyroid Carcinoma with High-Grade Features Versus Poorly Differentiated Thyroid Carcinoma: An Analysis of Clinicopathologic and Molecular Features and Outcome. Thyroid. 2021;31(6):933-40.

Article  CAS  PubMed  Google Scholar 

Xu B, David J, Dogan S, et al. Primary high-grade non-anaplastic thyroid carcinoma: a retrospective study of 364 cases. Histopathology. 2022;80(2):322-37.

Article  PubMed  Google Scholar 

Saliba M, Alzumaili BA, Katabi N, et al. Clinicopathologic and Prognostic Features of Pediatric Follicular Cell-derived Thyroid Carcinomas: A Retrospective Study of 222 Patients. Am J Surg Pathol. 2022;46(12):1659-69.

Article  PubMed  PubMed Central  Google Scholar 

Chernock RD, Rivera B, Borrelli N, et al. Poorly differentiated thyroid carcinoma of childhood and adolescence: a distinct entity characterized by DICER1 mutations. Mod Pathol. 2020;33(7):1264-74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu B, Lubin DJ, Dogan S, et al. Significance of oncocytic features in poorly differentiated thyroid carcinoma - a bi-institutional experience. Virchows Arch. 2023;482(3):479-91.

Article  CAS  PubMed  Google Scholar 

Hescot S, Al Ghuzlan A, Henry T, et al. Prognostic of recurrence and survival in poorly differentiated thyroid cancer. Endocr Relat Cancer. 2022;29(11):625-34.

CAS  PubMed  Google Scholar 

Landa I, Ibrahimpasic T, Boucai L, et al. Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. J Clin Invest. 2016;126(3):1052-66.

Article  PubMed  PubMed Central  Google Scholar 

Duan H, Li Y, Hu P, et al. Mutational profiling of poorly differentiated and anaplastic thyroid carcinoma by the use of targeted next-generation sequencing. Histopathology. 2019;75(6):890-9.

Article  PubMed  Google Scholar 

Kelly LM, Barila G, Liu P, et al. Identification of the transforming STRN-ALK fusion as a potential therapeutic target in the aggressive forms of thyroid cancer. Proc Natl Acad Sci U S A. 2014;111(11):4233-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gallant JN, Chen SC, Ortega CA, et al. Evaluation of the Molecular Landscape of Pediatric Thyroid Nodules and Use of a Multigene Genomic Classifier in Children. JAMA Oncol. 2022;8(9):1323-7.

Article  PubMed  PubMed Central  Google Scholar 

Yegen G, Altay AY, Yilmaz I, et al. DICER1 Mutations Do Not Always Indicate Dismal Prognosis in Pediatric Poorly Differentiated Thyroid Carcinomas. Endocr Pathol. 2023;34(3):279-86.

Article  CAS  PubMed  Google Scholar 

Whaley RD, Gupta S, Manninen MC, et al. Clinicopathologic and Molecular Analysis of 15 Pediatric and Young Adult Patients with High-Grade Non-anaplastic Thyroid Carcinoma. Endocr Pathol. 2024;35(4):397-410.

Article  CAS  PubMed  Google Scholar 

Schiavo Lena M, Sanchez-Ares M, Brunetto E, et al. Focal High-Grade Areas with a Tumor-in-Tumor Pattern: Another Feature of Pediatric DICER1-Associated Thyroid Carcinoma? Endocr Pathol. 2025;36(1):20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ver Berne J, Van den Bruel A, Vermeire S, De Paepe P. DICER1 Mutations Define the Landscape of Poorly Differentiated Thyroid Carcinoma in Children and Young Adults : Case Report and Literature Review. Am J Surg Pathol. 2024;48(10):1277-83.

Article  PubMed  Google Scholar 

Garcia EP, Minkovsky A, Jia Y, et al. Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer. Arch Pathol Lab Med. 2017;141(6):751-8.

Article  CAS  PubMed  Google Scholar 

Milbury CA, Creeden J, Yip WK, et al. Clinical and analytical validation of FoundationOne(R)CDx, a comprehensive genomic profiling assay for solid tumors. PLoS One. 2022;17(3):e0264138.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Frampton GM, Fichtenholtz A, Otto GA, et al. Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing. Nat Biotechnol. 2013;31(11):1023-31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thompson LDR. High Grade Differentiated Follicular Cell-Derived Thyroid Carcinoma Versus Poorly Differentiated Thyroid Carcinoma: A Clinicopathologic Analysis of 41 Cases. Endocr Pathol. 2023;34(2):234-46.

Article  CAS  PubMed  Google Scholar 

Scholfield DW, Xu B, Levyn H, et al. High-Grade Follicular Cell-Derived Non-Anaplastic Thyroid Carcinoma: Correlating Extent of Invasion and Mutation Profile with Oncologic Outcome. Thyroid. 2025;35(2):153-65.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wong KS, Lorch JH, Alexander EK, et al. Prognostic Significance of Extent of Invasion in Poorly Differentiated Thyroid Carcinoma. Thyroid. 2019;29(9):1255-61.

Article  PubMed  Google Scholar 

Metovic J, Vignale C, Annaratone L, et al. The Oncocytic Variant of Poorly Differentiated Thyroid Carcinoma Shows a Specific Immune-Related Gene Expression Profile. J Clin Endocrinol Metab. 2020;105(12):

Boos LA, Dettmer M, Schmitt A, et al. Diagnostic and prognostic implications of the PAX8-PPARgamma translocation in thyroid carcinomas-a TMA-based study of 226 cases. Histopathology. 2013;63(2):234-41.

Article  PubMed  Google Scholar 

Armstrong MJ, Yang H, Yip L, et al. PAX8/PPARgamma rearrangement in thyroid nodules predicts follicular-pattern carcinomas, in particular the encapsulated follicular variant of papillary carcinoma. Thyroid. 2014;24(9):1369-74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

French CA, Alexander EK, Cibas ES, et al. Genetic and biological subgroups of low-stage follicular thyroid cancer. Am J Pathol. 2003;162(4):1053-60.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nikiforova MN, Lynch RA, Biddinger PW, et al. RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. J Clin Endocrinol Metab. 2003;88(5):2318-26.

Article  CAS  PubMed  Google Scholar 

Sauer M, Barletta JA. Proceedings of the North American Society of Head and Neck Pathology, Los Angeles, CA, March 20, 2022: DICER1-Related Thyroid Tumors. Head Neck Pathol. 2022;16(1):190-9.

Article  PubMed  PubMed Central  Google Scholar 

Chong AS, Nikiforov YE, Condello V, et al. Prevalence and Spectrum of DICER1 Mutations in Adult-onset Thyroid Nodules with Indeterminate Cytology. J Clin Endocrinol Metab. 2021;106(4):968-77.

Article  PubMed  Google Scholar 

Khan NE, Bauer AJ, Schultz KAP, et al. Quantification of Thyroid Cancer and Multinodular Goiter Risk in the DICER1 Syndrome: A Family-Based Cohort Study. J Clin Endocrinol Metab. 2017;102(5):1614-22.